NI
63
5
L
54
5
ETN
64
4
ROP
44
6
ZTS
38
4
AAPL
64
3
WMB
58
3
MAS
46
3
ZION
49
9
SJM
17
5
FE
34
4
ROK
46
3
GWW
50
9
M
40
3
AXP
63
3
AIV
39
6
WMT
68
-2
JCI
44
7
SNA
56
3
JBHT
46
4
NI
63
5
L
54
5
ETN
64
4
ROP
44
6
ZTS
38
4
AAPL
64
3
WMB
58
3
MAS
46
3
ZION
49
9
SJM
17
5
FE
34
4
ROK
46
3
GWW
50
9
M
40
3
AXP
63
3
AIV
39
6
WMT
68
-2
JCI
44
7
SNA
56
3
JBHT
46
4
Financhill
Back

Rhythm Pharmaceuticals 10K Form

Buy
57

RYTM
Rhythm Pharmaceuticals

Last Price:
$56.05
Seasonality Move:
-14.94%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive RYTM News And Ratings

See the #1 stock for the next 7 days that we like better than RYTM

RYTM Financial Statistics

Sales & Book Value

Annual Sales: $77.4M
Cash Flow: $14.8M
Price / Cash Flow: 0
Annual Sales: $0.18
Price / Book: 307.53

Profitability

EPS (TTM): -4.33000
Net Income (TTM): $-258.9M
Gross Margin: $68.1M
Return on Equity: -208.96%
Return on Assets: -76.55%

Rhythm Pharmaceuticals Earnings Forecast

Key Rhythm Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 6 years for RYTM is 87.99%.
  • The Selling, General & Administrative Expenses for RYTM have been equal to 151.80% of Gross Profit Margin.
  • The Research & Development expenses have been 174.29% of Revenue.
  • The Interest Expense is -7.52% of Operating Income.
  • The Net Earning history of RYTM is -238.52% of Total Revenues.
  • Per Share Earnings over the last 9 years have been positive in 4 years.

Rhythm Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: RYTM
CUSIP: 76243J
Website: rhythmtx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 3.49
Quick Ratio: 3.25

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

RYTM Technical Analysis vs Fundamental Analysis

Buy
57
Rhythm Pharmaceuticals (RYTM) is a Buy

Is Rhythm Pharmaceuticals a Buy or a Sell?